Background
==========

The retina, which is exposed to both sunlight and very high levels of oxygen, is exceptionally rich in polyunsaturated fatty acids, which makes it a favorable environment for the generation of reactive oxygen species. For example, retinal pigment epithelium (RPE) generates a number of reactive oxygen species when illuminated with light \[[@B1]\]. Furthermore, phagocytosis of photoreceptor outer segments by RPE causes an increase in intracellular \[[@B2]\] and extracellular H~2~O~2~generation \[[@B3]\]. Oxidative stress has been suggested as the cause of a number of retinal pathological conditions \[[@B4],[@B5]\].

A number of *in vitro*studies have attempted to characterize the effect of oxidative stress on RPE. Depending on the experimental conditions, treatment of RPE with H~2~O~2~can cause an alteration of cellular functions \[[@B6],[@B7]\] or cell death \[[@B8],[@B9]\]. Cytotoxic levels of H~2~O~2~can cause significant mitochondrial \[[@B10]\] and genomic \[[@B11]\] DNA damage in RPE simulating the features of programmed cell death \[[@B8],[@B12]\]. Studies from other cell types indicate that early cellular events following H~2~O~2~treatment include morphological alterations and actin re-organization \[[@B13]\]. In addition, activation of the ERK (p42/44, Extracellular signal-Regulated Kinase) MAP kinases (Mitogen-Activated Protein kinases) can occur within minutes following cellular oxidative stress. Depending on the cell type examined, inhibition of the ERK activity can either prevent \[[@B14]\] or enhance H~2~O~2~-induced cell death \[[@B15]\]. The involvement of actin re-organization and ERK activation has not been examined in RPE under oxidative stress.

Lipid peroxidation products, such as 4-hydroxynonenal (4-HNE), have attracted considerable attention because of their potential involvement in aging and in a number of neuropathological conditions \[[@B16]\]. 4-HNE was implicated in the etiology of some pathological conditions in the eye. For example, levels of 4-HNE increased significantly in the vitreous of patients with proliferative vitreoretinopathy compared with controls \[[@B17]\]. Further, 4-HNE forms a stable adduct with rhodopsin in the photoreceptor, which may interfere with its functions \[[@B18]\]. 4-HNE even causes cataracts in cultured rat lens \[[@B19],[@B20]\]. Whether oxidative stress on RPE can cause accumulation of cellular HNE-protein adducts remains unknown.

Peroxisome proliferator-activated receptors (PPARs) belong to a group of nuclear receptors that include steroid, retinoid, thyroid hormone receptors and others \[[@B21]-[@B23]\]. There are three types of PPARs: PPARα is expressed predominantly in the liver, heart, kidney, brown adipose and stomach mucosa, and is important for lipid catabolism. PPARγ is found in adipose tissues and is important for adipogenesis. PPARβ is found in most tissues, but its role is less well defined. RPE cells express all three forms of PPARs but PPARβ is the dominant isoform \[[@B24]\]. There is a 10-fold induction of PPARγ mRNA that reaches a peak at 4-hour after phagocytosis of photoreceptor outer segments. The levels of either PPARα mRNA or PPARβ mRNA are not altered under the same conditions. Increases in PPARγ in RPE cells may be important for handling the lipids generated during the phagocytosis of photoreceptor outer segments \[[@B24]\]. Since RPE cells generate large amounts of H~2~O~2~during the phagocytosis of photoreceptor outer segments, there is a possibility that activation of PPARγ may assist in defending the oxidative stress associated with phagocytosis.

This study was designed to examine morphological alterations in RPE during oxidative stress, the involvement of ERK MAP kinase and 4-HNE and to test the hypothesis that PPARγ activation can prevent oxidative damage on RPE cells. The human RPE cell line, ARPE-19, and primary cultures of adult human RPE were used in this study. ARPE-19 is a spontaneous occurring, non-transformed RPE cell line which expresses RPE specific markers (such as CRALBP and RPE65) and exhibits morphological polarization and tight junctions similar to native RPE \[[@B25],[@B26]\].

Methods
=======

Materials
---------

WY14643, 15d-PGJ~2~, azelaoyl PAF and ciglitazone were purchased from Cayman (Ann Arbor, MI). LY 171883 was purchased from Alexis Biochemicals (San Diego, CA). AG126 and PD98059 were purchased from Calbiochem (San Diego, CA). Hydrogen peroxide and other pharmacological and general biochemical reagents were purchased from Sigma (St. Louis, MO) unless otherwise stated.

Cell cultures
-------------

*ARPE-19*cells \[[@B25]\] were obtained from the American Type Culture Collection and grown in DMEM/F12 containing 10% heat-inactivated fetal bovine serum and 2.5 mM glutamine. *Human primary RPE cultures*were established from donor eyes obtained from the Arkansas Lions Eye Bank & Laboratory. The globe was sectioned at the ora serrata, and the lens and vitreous body were removed. The eye cup was then filled with 4% dispase (prepared in DMEM) containing 1× antibiotic-antimycotic reagents (final concentrations: 100 units/ml Penicillin G, 100 μg/ml Streptomycin and 0.25 μg/ml Amphotericin B) and incubated in a 37°C incubator with 5% CO~2~for \~30 minutes. RPE cells were then removed under a dissecting microscope, dissociated by trituration using a Pasteur pipette, and then plated on poly-L-lysine (25 mg/liter in water) coated 35-cm^2^culture dishes. The cell population was then expanded by sequentially subculturing into 25-cm^2^tissue culture flasks, then to 75-cm^2^tissue culture flasks. Cells of passages \#3--\#6 were used for this study. The culture medium consisted of 10% heat-inactivated fetal bovine serum, 2.5 mM glutamine and 1× antibiotic-antimycotic reagents in DMEM.

Cell viability
--------------

Cells were plated in 96-well plates (human primary RPE: 10,000 cells/well, ARPE-19: 15,000--20,000 cells/well, unless otherwise stated) overnight, fed with serum-free medium or treated with testing agents (prepared in serum-free medium) the next day followed by H~2~O~2~treatment for a day, then the viability from each treatment was determined by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay \[[@B27]\]. Culture medium was removed after treatment and then 100 μl MTT solution (100 μg/ml prepared in DMEM) was added to each well. The cultures were incubated at 37°C for one hour in a tissue culture incubator. The MTT solution was then removed and the cells in each well were lysed by the addition of 100 μl dimethyl sulfoxide. The plate was placed on a shaker for one hour at room temperature to complete the lysing process, then the optical density of each well was measured by a 96-well plate reader with a filter setting at 570 nm (reference filter setting was 630 nm). When a pharmacological agent was used in the experiment, the MTT reading from cultures treated with that agent alone was used as 100% cellular viability.

Actin staining
--------------

This was performed as described by Carter et al. \[[@B28]\]. Cells grown on coverslips were treated with H~2~O~2~for various period of time as indicated in figure legends, washed three times with phosphate-buffered saline (PBS), then fixed for 10 minutes with 3.7% formaldehyde (prepared in PBS). The cultures were then washed three times with PBS, extracted with -20°C acetone for 5 minutes followed by three washes with PBS. Each culture was then stained with Texas Red-phalloidin (Molecular Probes, Eugene, OR) prepared in PBS containing 1% bovine serum albumin for 20 minutes at room temperature in a lightproof box. The cultures were then washed three times with water, mounted with GEL/MOUNT (Biomedia, Foster City, CA). The slides were examined under a Nikon microscope Eclipse E600 (Nikon Instruments Inc., Melville, NY). Cells were photographed digitally at a fixed exposure time by using a Photometrics CoolSNAP fx camera (Roper Scientific, Inc., Tucson, AZ) and the software MetaVue, Meta Imaging Series 4.5 (Universal Imaging Corporation, Downingtown, PA).

Immunohistochemical and immunofluorescent staining
--------------------------------------------------

Cultures grown on coverslips were used in this set of experiments. Phospho-ERK was detected by mouse anti-phospho-ERK antibody (Santa Cruz Biotechnology, Santa Cruz, CA, used at 1:1500) and the Vectastain ABC kit (Vector Lab., Burlingame, CA) with diaminobenzidine as the chromogen. Cellular 4-HNE protein adducts were detected by rabbit anti-4-HNE antibodies (Calbiochem, San Diego, CA, used at 1:250) followed by anti-rabbit secondary antibody labeled with FITC (Dako Corporation, Carpinteria, CA). The cultures were then mounted with GEL/MOUNT. The slides were examined under Nikon microscope Eclipse E600 (Nikon Instruments Inc., Melville, NY). Cells were photographed at fixed exposure time with Nikon digital still camera DXM 1200 (Nikon Instruments Inc., Melville, NY) and the software Nikon ACT-1 version 2.11 (Nikon Corporation, Tokyo, Japan).

Nuclear staining
----------------

Cells grown on coverslips were treated with H~2~O~2~for various periods of time as indicated in figure legends, fixed for 10 minutes with 3.7% formaldehyde (prepared in PBS), stained with 1 μg/ml bisbenzimide solution (Hoechst 33258, Sigma, St. Louis, MO) for 10 minutes at room temperature, mounted with GEL/MOUNT, then observed under a fluorescent microscope as described in the previous section.

Western blot analysis
---------------------

RPE cells were plated in T-150 flasks overnight, fed with serum-free medium for a day, then treated with H~2~O~2~as indicated in figure legends. For sample preparation, cultures were detached with a scraper in PBS then centrifuged. The cell pellets were suspended in 150--300 μl ice-cold RIPA lysis buffer (1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS in PBS, 0.5 mM Phenylmethylsulfonyl fluoride (PMSF), 0.02 mg/ml Aprotinin, 1 mM Na~3~VO~4~) and incubated for 30 min on ice. Each sample was further homogenized by passage through a 21-gauge needle followed by an addition of 10 μl PMSF (stock solution: 50 mM). The samples were then incubated for 30 min on ice and subsequently centrifuged at 14,000 RPM for 20 min at 4°C. The supernatant from each sample was collected and an aliquot was taken for protein concentration determination by Micro BCA Protein Assay Reagent Kit (Pierce, Rockford, IL). Protein samples were stored at -70°C until ready for electrophoretic analysis. Equal amounts of protein samples (20 μg/well) were heated at 95°C for 6 min then loaded onto 1% SDS, 10% polyacrylamide gels. BenchMark pre-stained protein ladder (Invitrogen life technologies, Carlsbad, California) was used as molecular weight standards. Following electrophoretic separation, the proteins were transferred to nitrocellulose membranes. Equal loading and appropriate transfer of each lane was confirmed by staining the membrane with the Ponceau S solution (Sigma, St. Louis, MO). Membranes were blocked in 5% nonfat dried milk for one hour, washed in 10 mM Tris-buffered saline (pH 7.5) containing 0.1% Tween-20 (TBST) and probed with primary antibody overnight at 4°C. Membranes were washed with TBST and then incubated for 1 hour at room temperature with a secondary antibody followed by washing three times with TBST, immersed in ECL Plus western blotting detection system (Amersham Pharmacia Biotech, Buckinghamshire, England) for 1 min and then exposed to Kodak X-ray film (Rochester, NY). The films were analyzed by densitometry using a ChemiImager 5500 imaging system with AlphaEaseFC software (Alpha Innotech Corporation, San Leandro, CA). Results, expressed as percentage of control, from replicate experiments were pooled and averaged. The primary antibodies used in this set of experiments were from Santa Cruz (anti-ERK 1/2, used at 1:5000; anti-phospho-ERK, used at 1:1000; anti-PPARγ, used at 1:2000) or from Calbiochem (anti-4-HNE, used at 1:2,000).

Statistical analysis
--------------------

Unless otherwise stated, results of cell viability experiments were pooled from 12 replicate samples derived from 3 independent experiments, and expressed as mean ± SEM. Statistical analyses were performed by analysis of variance (one-way ANOVA) followed by the Bonferroni test to determine the significance of difference.

Results
=======

Cytotoxicity of H~2~O~2~toward primary human RPE and ARPE-19 cells
------------------------------------------------------------------

Initial experiments analyzing the cytotoxic effect of oxidative stress on primary cultures of human RPE cells indicated that H~2~O~2~at 1 mM or less did not affect cellular viability. Higher concentrations caused a sharp decrease of viability in human RPE such that a 24-hour treatment of cells with 1.2 mM H~2~O~2~lowered the viability to 13% of controls (Fig. [1A](#F1){ref-type="fig"}, squares). This concentration lowered the viability of human RPE to 62% after a 4-hour treatment (Fig. [1A](#F1){ref-type="fig"}, circles).

![Cytotoxicity of H~2~O~2~on human RPE cells. Fig. [1A](#F1){ref-type="fig"}: Primary human RPE cells were plated in 96-well plate, fed with serum-free medium the next day, then treated with H~2~O~2~for 4 hours (circles) or 24 hours (squares). Fig. [1B](#F1){ref-type="fig"}: ARPE-19 cells were plated in 96-well plate, fed with serum-free medium the next day, then treated with H~2~O~2~for 4 hours (circles) or 24 hours (squares). Fig. [1C](#F1){ref-type="fig"}: ARPE-19 cells were plated with a density of 10,000 cells/well, 20,000 cells/well or 40,000 cells/well in 96-well plates, fed with serum-free medium the next day, then treated with H~2~O~2~for 24 hours. The viability of each treatment was determined by the MTT assay. Cultures at a density of 40,000 cells/well were 100% confluent.](1471-2415-3-5-1){#F1}

In a set of analogous experiments, ARPE-19 cells treated with various concentrations of H~2~O~2~for 4 hours or 24 hours showed that a 4-hour treatment with 1 mM H~2~O~2~did not affect viability. An increase of H~2~O~2~concentrations beyond 1 mM decreased viability such as 2 mM H~2~O~2~decreased the viability to 46% of controls in 4 hours (Fig. [1B](#F1){ref-type="fig"}, circles). Treatment of cells with H~2~O~2~for 24 hours caused a dose-dependent decrease of viability with a LD~50~of \~1.35 mM (Fig. [1B](#F1){ref-type="fig"}, squares).

H~2~O~2~induced cytotoxicity in RPE cells appears to be affected by the density of cells in cultures \[[@B29]\]. To study this phenomenon, ARPE-19 cells plated in 96-well plates with densities of 10,000, 20,000 or 40,000 cells/well were subjected to H~2~O~2~treatment. Cells grown in a high-density culture were indeed more resistant to H~2~O~2~as compared to those grown in a low-density culture (Fig. [1C](#F1){ref-type="fig"}). For example, H~2~O~2~at 1.4 mM reduced cellular viability to 11%, 49% or 94% of control in cultures with 10,000, 20,000 or 40,000 cells/well, respectively.

H~2~O~2~induced morphological alterations and formation of 4-HNE-adducts
------------------------------------------------------------------------

To analyze morphological changes of RPE cells treated with a cytotoxic concentration of H~2~O~2~, ARPE-19 cells were treated with 1.5 mM H~2~O~2~for various periods of time and then processed for actin staining. Without H~2~O~2~treatment, stress fibers appeared thin and diffuse in control cells (Fig. [2A](#F2){ref-type="fig"}, arrow). At 15-min after treatment, these cells appeared to round up and significant ruffling occurred at the edge of their plasma membrane (Fig. [2B](#F2){ref-type="fig"}, arrows). Overall thickening of stress fibers occurred at two hours after treatment in addition to the membrane ruffling (Fig. [2C](#F2){ref-type="fig"}, arrows). Additional morphological changes after 4 hours of H~2~O~2~treatment (Fig. [2D,2E,2F](#F2){ref-type="fig"}) included distinctive dense bands at the periphery of some cells (Fig. [2D](#F2){ref-type="fig"}, arrows), peri-nuclear staining of actin fibers in other cells (which made the nuclei prominent, Fig. [2E](#F2){ref-type="fig"}, arrows) and microspikes (Fig. [2F](#F2){ref-type="fig"}, arrow) on the cell surface of some cells.

![Reorganization of actin fibers caused by oxidative stress. ARPE-19 cells were treated with 1.5 mM H~2~O~2~then processed for actin stain as described in the Methods. Fig. [2A](#F2){ref-type="fig"}: untreated; Fig. [2B](#F2){ref-type="fig"}: 15-min; Fig. [2C](#F2){ref-type="fig"}: 2-hour; Figs. [2D,2E](#F2){ref-type="fig"} and [2F](#F2){ref-type="fig"}: 4-hour after treatment. See text for detailed discussion of the results. Scale bar in Fig. [2F](#F2){ref-type="fig"}: 50 μm.](1471-2415-3-5-2){#F2}

Subsequent experiments with immunofluorescent staining indicated that 1.5 mM H~2~O~2~treatment of ARPE-19 cells for 4 hours led to the formation of 4-HNE protein adducts both in the cytoplasm and nucleus, presumably as a result of lipid-peroxidation (Fig. [3A,3B](#F3){ref-type="fig"}). Various protein bands on Western blots were positive for anti-HNE antibody reactivity, further intensified as a result of H~2~O~2~treatment (Fig [3C](#F3){ref-type="fig"}). Densitometry measurements were performed to estimate the collective increase of band intensity in each lane between 39 Kd and 87 Kd. Results derived from a total of six independent experiments indicated that treatment of cells with 0.5, 1, 1.5 or 2 mM H~2~O~2~caused an increase of intensity to 2.5-, 3.1-, 3.7- or 7.1-fold of control, respectively.

![H~2~O~2~induced lipid peroxidation in RPE. ARPE-19 cells were treated with 1.5 mM H~2~O~2~for 4 hours then processed for immunofluorescent staining using antibodies against 4-HNE. Fig. [3A](#F3){ref-type="fig"}: untreated cells. Scale bar: 50 μm. Fig. [3B](#F3){ref-type="fig"}: H~2~O~2~treated cells. Note the overall enhanced staining in nucleus and cytoplasm. Fig. [3C](#F3){ref-type="fig"}: ARPE-19 cells were treated with various concentrations (0.5, 1, 1.5, 2 mM) of H~2~O~2~for 24 hours then processed for Western blot analysis using anti-4-HNE antibodies. These polyclonal antibodies recognize cysteine-, histidine- and lysine-4-HNE Michael adducts. This is a representative result from 6 similar experiments.](1471-2415-3-5-3){#F3}

Though there was significant cytoskeletal alterations and lipid peroxidation at 4 hours after H~2~O~2~treatment, nuclear staining using bisbenzimide (Hoechst 33258) indicated that most cells maintained normal nuclear morphology at this time (Fig. [4A](#F4){ref-type="fig"}, untreated cells; Fig. [4B](#F4){ref-type="fig"}, 4 hours after treatment). Nuclear condensation increased with length of H~2~O~2~exposure, which was clearly evident at 12 hours after H~2~O~2~treatment (Fig [4C](#F4){ref-type="fig"}, arrows), and even more prominent at 16 hours after treatment (Fig. [4D](#F4){ref-type="fig"}). These results suggest that H~2~O~2~treatment caused apoptosis in RPE. Nuclear condensation appeared to start at the edge of the culture (relatively lower density area, Fig. [4C](#F4){ref-type="fig"}, arrows) and spread to the center part of the culture (higher density, Fig. [4D](#F4){ref-type="fig"}) over time. This phenomenon is consistent with the viability assay in which higher density cultures were more resistant to oxidative stress (Fig. [1C](#F1){ref-type="fig"}).

![H~2~O~2~induced nuclear condensation in ARPE-19 cells. ARPE-19 cells were treated with 1.5 mM H~2~O~2~for various periods of time, and then processed for nuclear staining. Fig. [4A](#F4){ref-type="fig"}: untreated cells; Fig. [4B](#F4){ref-type="fig"}: 4-hour; Fig. [4C](#F4){ref-type="fig"}: 12-hour; Fig. [4D](#F4){ref-type="fig"}: 16-hour after treatment. Fig. [4E](#F4){ref-type="fig"}: Cells were pretreated with 1 μM 15d-PGJ~2~overnight, followed by 1.5 mM H~2~O~2~for 16 hours (without 15d-PGJ~2~). See text for detailed description of the results. Scale bar in Fig. [4E](#F4){ref-type="fig"}: 100 μm.](1471-2415-3-5-4){#F4}

Effect of oxidative stress on PPARγ protein expression
------------------------------------------------------

During rod outer segment ingestion, there is a generation of H~2~O~2~\[[@B2],[@B3]\] and an up-regulation of PPARγ mRNA expression \[[@B24]\] in RPE, experiments were performed to determine if H~2~O~2~could induce PPARγ protein expression over the control levels. ARPE-19 cells were treated with various concentrations (0.5, 1, 1.5, 2 mM) of H~2~O~2~for 24 hours and processed for Western blot analysis. Results indicated a slight induction of PPARγ protein levels in some experiments. This induction, however, was not apparent in other experiments (Results not shown). Densitometry analyses from a total of six independent experiments indicated that treatment of these cells with 0.5, 1, 1.5 or 2 mM H~2~O~2~for 24 hours caused an alteration of band intensity to 76%, 108%, 113% or 104% of controls, respectively. There was no significant change of PPARγ protein level after 30-min or 12-hour H~2~O~2~treatment, either (results not shown). A separate set of experiments also indicated that treatment of primary human RPE cells with 1 mM H~2~O~2~for 24 hours did not induce PPARγ protein expression over the control levels (results not shown).

Prevention of oxidative stress induced cytotoxicity by PPARγ agonists
---------------------------------------------------------------------

Even though H~2~O~2~did not increase PPARγ protein expression significantly as indicated in the previous study, experiments were performed to determine whether PPARγ agonists could activate the existing PPARγ thus preventing H~2~O~2~induced cytotoxicity in RPE cells. Cells were pretreated with the PPARγ agonist 15d-PGJ~2~overnight followed by H~2~O~2~for one day (without 15d-PGJ~2~) and processed for the MTT viability assay. Results indicated that 15d-PGJ~2~prevented H~2~O~2~induced cytotoxicity in primary human RPE cultures in a dose-dependent manner (Fig. [5A](#F5){ref-type="fig"}). Subsequent experiments with ARPE-19 cells also indicated this saving effect. While H~2~O~2~at 1.3 mM, 1.4 mM or 1.5 mM lowered the ARPE-19 viability to 64%, 46% or 28% of control, respectively; pretreatment of these cells with 1 μM 15d-PGJ~2~raised the viabilities to 95%, 84% or 68% of control, respectively (Fig. [5B](#F5){ref-type="fig"}). Cells stained with Hoechst 33258 indicated that 15d-PGJ~2~prevented H~2~O~2~induced nuclear condensation (Fig. [4E](#F4){ref-type="fig"}; compare this with Fig. [4D](#F4){ref-type="fig"}). The other PPARγ agonists, ciglitazone \[[@B30]\], azelaoyl PAF \[[@B31]\] and LY171883 \[[@B32]\], however, were not effective (tested between 1--10 μM, 3 independent experiments for each agent, results not shown). The PPARα agonist WY14643 had some saving effect at a high concentration (40 μM), however, the difference was not statistically significant (results not shown).

![Prevention of H~2~O~2~induced cytotoxicity by 15d-PGJ~2~in RPE cells. Fig. [5A](#F5){ref-type="fig"}: Primary RPE cells were pretreated with various concentrations of 15d-PGJ~2~overnight, followed by 1.3 mM or 1.4 mM H~2~O~2~for 1 day (without 15d-PGJ~2~), then processed for the MTT viability assay. Fig. [5B](#F5){ref-type="fig"}: ARPE-19 cells were pretreated with 1 μM 15d-PGJ~2~overnight, followed by various concentrations of H~2~O~2~for 1 day (without 15d-PGJ~2~), then processed for the MTT viability assay. Statistical analyses were performed comparing cells treated with H~2~O~2~alone versus H~2~O~2~plus 15d-PGJ~2~.](1471-2415-3-5-5){#F5}

Activation of ERK by H~2~O~2~
-----------------------------

A set of experiments was performed to determine the effects of H~2~O~2~on ERK activation. ARPE-19 cells were treated with 1.5 mM H~2~O~2~for 1 hour and processed for immunohistochemical staining using antibodies against phospho-ERK. Untreated cells showed a faint phospho-ERK staining while there was an apparent increase of phospho-ERK staining in the cytoplasm and nuclei in H~2~O~2~treated cells (Fig. [6A,6B](#F6){ref-type="fig"}). A separate set of cultures was treated with H~2~O~2~for 30 min and then processed for Western blot analysis. This H~2~O~2~treatment of the cells caused only a slight alteration in ERK levels but led to a dose-dependent increase of phospho-ERK, with a maximal stimulation observed at 1.5 mM (Fig. [6C](#F6){ref-type="fig"}). Densitometry analyses from 3 independent experiments indicated that 0.5, 1, 1.5 or 2 mM H~2~O~2~caused an increase of p42ERK (ERK2) phosphorylation to 2.1-, 12.7-, 18.8- or 2.0- fold of control, respectively. Similar treatment caused an increase of p44 ERK (ERK1) phosphorylation to 1.5-, 15.7-, 21.4- or 3.4-fold of control, respectively. The phospho-ERK in H~2~O~2~treated samples remained higher than control at 24-hour after treatment (results not shown).

![Activation of ERK by H~2~O~2~treatment. ARPE-19 were treated with 1.5 mM H~2~O~2~for one hour, then processed for immunohistochemical staining using anti-phospho-ERK antibody. Fig. [6A](#F6){ref-type="fig"}: untreated cells. Scale bar: 50 μm. Fig. [6B](#F6){ref-type="fig"}: H~2~O~2~treated cells. Fig. [6C](#F6){ref-type="fig"}: ARPE-19 were treated with various concentrations (0.5, 1, 1.5, 2 mM) of H~2~O~2~for 30 minutes, and then processed for Western blot analysis. Antibodies against ERK and phospho-ERK were used in this study. P: positive controls. This is a representative result from 3 similar experiments.](1471-2415-3-5-6){#F6}

Effect of ERK inhibition on H~2~O~2~induced cytotoxicity in ARPE-19
-------------------------------------------------------------------

Since ERK activation appeared to be an early event associated with H~2~O~2~induced cytotoxicity, experiments were performed to determine if inhibitors of ERK activation could affect the cytotoxicity caused by H~2~O~2~. ARPE-19 cells were pretreated with 10 μM PD98059 (a MEK inhibitor which functions upstream of ERK \[[@B33]\]) followed by H~2~O~2~challenge. Results from 3 independent experiments indicated that this agent could prevent low-dose (1--1.2 mM) H~2~O~2~induced cell death slightly. In contrast, it enhanced high-dose (1.3--1.6 mM) H~2~O~2~induced cell death. These effects in either case were not remarkable (results not shown). This agent at concentrations higher than 10 μM was toxic to ARPE-19 cells by itself and could enhance H~2~O~2~toxicity (results not shown).

In a separate set of experiments, ARPE-19 cells were pretreated with 10 μM AG126 (a protein tyrosine kinase inhibitor \[[@B34]\]) followed by H~2~O~2~challenge. The treatment of cells with 1.3 mM, 1.4 mM or 1.5 mM H~2~O~2~decreased the cellular viability to 66%, 40% or 22% of control, respectively. Pretreatment of cells with AG126 raised the viability to 72% (p \< 0.05 compared to H~2~O~2~treatment only), 63% (p \< 0.005) or 35% (p \< 0.01) of control, respectively. AG126 at concentrations higher than 10 μM was toxic to ARPE-19 cells by itself and could enhance H~2~O~2~toxicity (results not shown).

Both AG126 (10 μM) and 15d-PGJ~2~(1 μM) could prevent H~2~O~2~induced cytotoxicity in ARPE-19, a set of experiments was also performed to determine whether these two agents had additive saving effects. While 1.4 mM H~2~O~2~treatment reduced the viability to \~40% of control, AG126 raised this viability to \~55% of control and 15d-PGJ~2~raised the viability to 75% of control. A combination of these two agents did not raise the viability above 15d-PGJ~2~alone (Fig. [7](#F7){ref-type="fig"}).

![Saving of RPE cells by AG126 and 15d-PGJ~2~. ARPE-19 cells were treated with 10 μM AG126, 1 μM 15d-PGJ~2~or a combination of these two agents overnight, followed by 1.4 mM H~2~O~2~for 1 day (without testing agents), then processed for the MTT viability assay. \*P \< 0.05 as compared to H~2~O~2~alone; \*\*p \< 0.001 as compared to H~2~O~2~alone. There was no statistical difference between H~2~O~2~+15d-PGJ~2~and H~2~O~2~+AG/15d-PGJ~2~.](1471-2415-3-5-7){#F7}

Discussion
==========

Cytotoxicity of oxidative stress on RPE
---------------------------------------

Results from this study indicated that both primary human RPE cultures and ARPE-19 cells were susceptible to H~2~O~2~treatment. It is important to point out that H~2~O~2~showed a very steep dose-response curve in primary RPE cultures under our experimental conditions such that an increase of H~2~O~2~concentration from 1 mM to 1.2 mM for one-day treatment caused a decrease in viability from \~100% to \~10% of control (Fig. [1A](#F1){ref-type="fig"}). Though the H~2~O~2~titration curve in ARPE-19 was not as steep as observed in primary RPE, one-day treatment of these cells with 1.8 mM H~2~O~2~could decrease the cellular viability to \~10% of control while 1 mM H~2~O~2~did not affect cellular viability (Fig. [1B](#F1){ref-type="fig"}). The sharp dose-response curves demonstrated in this study suggests that it is important to have an effective cellular anti-oxidation mechanism to prevent the build-up of oxidative stress over a critical level. An increase of oxidative stress in RPE is associated with an increase of cellular catalase, metallothionein \[[@B3]\] and glutathione S-transferase \[[@B35]\], which should serve as a protective mechanism to decrease the cytotoxicity caused by H~2~O~2~and other reactive oxygen species. This protective mechanism declines with age because a study analyzing metallothionein levels in RPE of macular region showed a dramatic decrease in aged donors (mean age = 80-yr) as compared to those from younger donors (mean age = 58-yr) \[[@B36]\]. A separate report concluded that there was also an age-dependent decrease of catalase activity in RPE \[[@B37]\]. These studies suggest RPE in the elderly are more susceptible to oxidative stress induced damage, which may contribute to age-related RPE dysfunction and vision loss. The oxidative stress induced RPE cytotoxicity can be aggravated by zinc deficiency, as previously reported by Tate et al. \[[@B9]\].

Significant morphological changes were observed in RPE cells treated with a cytotoxic concentration of H~2~O~2~. Actin fiber re-organization was noticed as early as 15 minutes after treatment (Fig. [2](#F2){ref-type="fig"}). Those images presented in Fig. [2D,2E](#F2){ref-type="fig"} and [2F](#F2){ref-type="fig"} are three representatives of RPE cells at 4 hr after H~2~O~2~treatment. The cells shown in 2D and 2F are commonly seen at different locations on the same slide. In Fig. [2D](#F2){ref-type="fig"}, the dense peripheral bands of actin fibers were very prominent in some cells and the high intensity fluorescence caused an impression that the cells were relatively empty. The thickening of dense peripheral bands in this study was in contrast to previous observations in endothelial cells. For example, Zhao and Davis reported that cultured pulmonary endothelial cells treated with H~2~O~2~underwent a morphological change that was accompanied by an accumulation/increase in stress fibers running across the cells while the dense peripheral bands of most cells were disrupted or eliminated \[[@B38]\]. Similar observations on endothelial cells were made by Liu and Sundqvist \[[@B39]\]. The dense peripheral bands are important in cell-cell adhesion, which maintains the structural integrity. While it is apparent that endothelial cells used in those studies and epithelial cells used in this study respond differently to H~2~O~2~, the underlying reason for this difference is currently unknown. One may speculate that RPE cells use this build-in mechanism to defend the oxidative stress that they are constantly exposed to. We currently have no data to support or dismiss this possibility. In Fig. [2E](#F2){ref-type="fig"}, some cultures responded to H~2~O~2~treatment by a perinuclear distribution of actin fibers. In Fig. [2F](#F2){ref-type="fig"}, we observed microspikes at the periphery of the cells. A detailed study of microspikes by Adams indicated that these structures consist of actin, the actin binding protein, 55 kd/fascin and myosin \[[@B40]\]. The perinuclear staining and microspikes of cells under oxidative stress in this study are very similar to those observed by Huot et al. in endothelial cells treated with H~2~O~2~\[[@B41]\]. The functional significance of these structural changes in RPE after H~2~O~2~treatment is not clear. There is a possibility that the appearance of microspikes around the cells under stressed conditions is an adapted behavior of the cells in order to attach to the substratum firmly. Prolonged H~2~O~2~treatment led to cell death with the appearance of condensed nuclei is an indication of apoptosis (Fig. [4C,4D](#F4){ref-type="fig"}). This general finding is consistent with that observed by others \[[@B8],[@B12]\].

It is of interest to note that cultures with a reduced density are more vulnerable to H~2~O~2~treatment (Fig. [1C](#F1){ref-type="fig"}). One straightforward explanation for the vulnerability of low-density cultures treated with H~2~O~2~is that more molecules of H~2~O~2~per cell were present in these low-density cultures, which caused a lower viability. If this were the case, a mathematic analysis of the H~2~O~2~molecules per cell should be able to estimate the cytotoxicity in this experimental system. For example, 1.4 mM H~2~O~2~in a culture plated at a density of 40,000 cells/well should result in a viability close to twice of that generated in 20,000 cells/well and four times of that in 10,000 cells/well. Results from Fig. [1C](#F1){ref-type="fig"} indicated that the viability of each condition above was 94%, 49% or 11%, respectively. It is apparent that H~2~O~2~killed more cells in cultures of lower density (10,000 cells/well) than expected. Because the result could not always be predicted by a mathematic estimation, there is a possibility that cell-cell contacts and some autocrine/paracrine production in a culture may alter the microenvironment thus determine the cytotoxicity caused by H~2~O~2~. Since cells with lower density are more susceptible to oxidative stress, there is a possibility that a vicious cycle exists such that when an area of RPE loses some of the constituent cells by oxidative stress, the remaining cells will become even more vulnerable to this insult.

PPARs in RPE
------------

This study indicated that the PPARγ agonist 15d-PGJ~2~could prevent H~2~O~2~induced RPE cell death (Figs. [5A,5B](#F5){ref-type="fig"} and Fig. [4E](#F4){ref-type="fig"}). This suggests that this agent can prevent oxidative stress induced RPE damage. This finding is significant given prior reports that oxidative stress on RPE is an important contributing factor of age-related macular degeneration \[[@B5],[@B42]\]. An earlier report also indicated that PPARγ agonists could prevent laser photocoagulation induced choroidal neovascularization in rat eyes and monkey eyes, which suggests the possible application of these agents on the exudative form of age-related macular degeneration \[[@B43]\]. It is important to note that the other PPARγ agonists tested in this study (ciglitazone, azelaoyl PAF and LY171883) were ineffective in saving cells under the same experimental conditions. Since three out of four PPARγ agonists tested were ineffective, this raises the possibility that the saving effect of 15d-PGJ~2~is not through PPARγ activation. In this respect, it should be noted that this agent has been shown to exert some biological effects that are independent of PPARγ activation \[[@B44]-[@B46]\].

We have previously shown that 15d-PGJ~2~can prevent the cytotoxicity of cholesterol oxides, end products of cholesterol under oxidative stress \[[@B27]\]. Together with results from the current study, this agent may have a general protective effect against oxidative stress itself or against cytotoxic agents generated by oxidative stress. It is important to note that 15d-PGJ~2~functions as a general inhibitor of immune activities. For example, this agent is a potent inhibitor of microglia, the macrophage-like cells in the central nervous system \[[@B47]-[@B49]\] and shown to be effective in reducing the symptoms of experimental autoimmune encephalomyelitis (EAE), an animal model for the human disease multiple sclerosis \[[@B50]\]. Together, these results suggest that this agent may be useful in preventing ocular diseases that result from oxidative stress or inflammation.

ERK activation and 4-HNE protein adducts formation as a result of oxidative stress
----------------------------------------------------------------------------------

Oxidative stress is a potent stimulator of the MAP kinase activities \[[@B14],[@B15],[@B51]\]. Phosphorylation of ERK could be observed within 30--60 minutes after H~2~O~2~treatment (Fig. [6](#F6){ref-type="fig"}). There are conflicting results in literature regarding whether an increase of ERK phosphorylation is beneficial or detrimental to cell survival. Bhat et al. demonstrated that 5--25 μM PD98059 could prevent H~2~O~2~induced cell death in an oligodendrocyte cell line \[[@B14]\]. In contrast, 20 μM PD98059 was shown to enhance cell death caused by H~2~O~2~treatment in HeLa cells \[[@B15]\]. This reagent had no significant effect on H~2~O~2~treated ARPE-19 cells under our experimental conditions. AG126, on the other hand, appeared to reduce the cytotoxicity caused by oxidative stress (Fig. [7](#F7){ref-type="fig"}). While this suggests that inhibition of tyrosine phosphorylation or ERK activation after H~2~O~2~treatment might be beneficial for the cells, results from PD98059 could not support this statement.

There is a possibility that the saving effect of AG126 is not related to ERK inhibition. Under the current experimental conditions, AG126 at 10 μM was protective but it enhanced H~2~O~2~toxicity at 20 μM. These results were consistent with those reported by Sagara et al. \[[@B52]\]. AG126 belongs to a group of tyrosine kinase inhibitors named tyrphostins. Many of these agents can prevent cellular oxidative stress including that generated by glutamate. There is no correlation between the kinase inhibition and the observed protective effect. Overnight treatment of cells with AG126 can increase cellular glutathione levels. Furthermore, this agent has some anti-oxidant effect based on the Trolox Equivalent Activity Concentration \[[@B52]\]. Collectively, this may explain the observation that AG126 at 10 μM could partially prevent H~2~O~2~induced cytotoxicity. This agent can also function as a mitochondria uncoupler, thus it actually enhances H~2~O~2~cytotoxicity at higher concentrations \[[@B52]\].

An accumulation of 4-HNE-conjugated protein has been detected in lesions of aging-related diseases, including Parkinson\'s disease \[[@B53]\] and Alzheimer\'s disease \[[@B54]\]. It also accumulates in the affected neuronal tissues of experimental animals experiencing brain ischemia \[[@B55],[@B56]\] and traumatic spinal cord injury \[[@B57]\]. 4-HNE can impair synaptosomal membrane proteins, glutamate transport and importantly, mitochondrial functions \[[@B58],[@B59]\]. Evidence indicates that 4-HNE increases neuronal susceptibility to oxidative stress \[[@B60]\] and serves as a mediator of oxidative stress that leads to neuronal apoptosis \[[@B61]\]. As indicated in the Introduction, 4-HNE has been implicated in some ocular pathological conditions \[[@B19],[@B20]\].

Several laboratories have attempted to document the formation of 4-HNE protein adducts during oxidative stress by Western blot analysis. Uchida et al. first reported oxidative stress caused by t-butylhydroperoxide or iron/ascorbate could lead to 4-HNE protein adducts in hepatocytes \[[@B62]\]. Further studies by these researchers attempted to identify the common epitope recognized by the 4-HNE antibodies. However, no specific protein was positively identified \[[@B63]\]. More recently, the formation of 4-HNE protein adducts was also demonstrated by Western blot analysis from the heart \[[@B64]\], the liver \[[@B65]\] and the kidney \[[@B66]\] under oxidative stress. It is important to point out that the patterns of 4-HNE protein adducts, as shown by these Western blot analyses, were different among these studies, probably as a result of tissue specificity. No particular protein was identified as a specific target for 4-HNE adduct formation in these studies. Results from the current study indicate that H~2~O~2~treatment of RPE could lead to the accumulation of 4-HNE protein adducts in the cytoplasm and the nuclei of these cells (Fig. [3](#F3){ref-type="fig"}). There was a dose-dependent increase of 4-HNE protein adduct after H~2~O~2~treatment with a maximal intensity of \~7X control at 2 mM H~2~O~2~(Fig. [3C](#F3){ref-type="fig"}). This may partially contribute to oxidative stress induced ocular disease. Even though ocular tissues, including the retina, contain glutathione S-transferases that can actively detoxify 4-HNE \[[@B35],[@B67]\], adverse events may occur if aging or pathological conditions hinder this normal defense from functioning properly. It warrants further studies to identify those proteins species that are modified by 4-HNE.

Conclusions
===========

This study demonstrates that oxidative stress induced by H~2~O~2~could lead to RPE cell death, which is preceded by distinct morphological changes, ERK activation and 4-HNE protein adduct formation. The cell death can be prevented partially by AG126, and the prostaglandin derivative, 15d-PGJ~2.~These agents may be useful pharmacological tools in the future capable of preventing oxidative stress induced RPE cell death in human ocular diseases.
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